Age [Years], Sex |
Age at DLB Onset [Years] |
Medication for DLB [mg/day] |
Age at RBD Onset [Years] |
RBD Duration [Years] |
PSQI 5(h) | Motor and Vocal Behavior after 12 Weeks of Tiaprid |
Final Tiaprid Dosage [mg] |
||
---|---|---|---|---|---|---|---|---|---|
Before | After 12 Weeks |
Patient | Bed Partner |
||||||
72, male | 68 | levodopa/carbidopa 200/50 rivastigmine patch 4.6 |
66 | 6 | 3 | 1 | + | + | 50* |
73, male | 70 | levodopa/carbidopa 400/100 rivastigmine capsules 12 pramipexole 1,05 |
71 | 2 | 2 | 0 | + | + | 100 |
78, male | 72 | levodopa/carbidopa 600/150 rivastigmine patch 9.5 rotigotine patch 8 |
75 | 3 | 2 | 2 | = | = | 100 |
74, male | 72 | levodopa/carbidopa 400/100 rivastigmine patch 9.5 |
71 | 3 | 3 | 0 | + | + | 50 |
71, female | 70 | levodopa/carbidopa 300/75 donepezil 5 |
70 | 1 | 2 | 1 | + | = | 100 |
63, male | 61 | levodopa/carbidopa 300/75 donepezil 10 |
62 | 1 | 2 | 1 | + | + | 150 |